Cargando…
EGFR敏感突变的NSCLC脑转移患者治疗模式之争：临床到底该如何选择？
Brain metastasis of epidermal growth factor receptor (EGFR) sensitive mutations is a hot and difficult point in targeted era of non-small cell lung cancer (NSCLC) treatment, meanwhile it is also the central issue of controversy in the field of lung cancer treatment. Different results of different st...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467988/ https://www.ncbi.nlm.nih.gov/pubmed/32746605 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.29 |